We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie Enters Partnership to Develop COVID-19 Antibody Therapies
AbbVie Enters Partnership to Develop COVID-19 Antibody Therapies
AbbVie has entered into a partnership with Harbour BioMed (HBM), Utrecht University (UU) and Erasmus Medical Center (EMC) to develop a monoclonal antibody therapy for COVID-19.